Myriad Genetics board member Skovronsky resigns
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Join SI Premium – FREE
Daniel M. Skovronsky, M.D., Ph.D., a member of the board of directors of Myriad Genetics (NASDAQ: MYGN), resigned from his position effective June 17, 2026.
According to a company statement, Skovronsky's departure was not the result of any disagreement with the company or any matter relating to its operations, policies, or practices.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RH promotes Sandy Pilon to chief customer experience & values officer
- Ryder System (R) Tops Q2 EPS by 5c ; Offers Guidance
- Ouster names Shaluinn Fullove as chief people officer
Create E-mail Alert Related Categories
Corporate News, Management ChangesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
